Leslie A McClure Selected Research

Secondary Prevention

12/2021	Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?
1/2021	The Relationship Between Glucose Control and Cognitive Function in People With Diabetes After a Lacunar Stroke.
1/2020	Functional health and white matter hyperintensities as effect modifiers of blood pressure-lowering on cognitive function and vascular events in older Secondary Prevention of Small Subcortical Strokes trial participants.
8/2019	Effect of Postural Hypotension on Recurrent Stroke: Secondary Prevention of Small Subcortical Strokes (SPS3) Study.
1/2019	Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
1/2019	Genome-wide association analysis of common genetic variants of resistant hypertension.
8/2017	Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
1/2017	Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
10/2016	A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.
7/2016	Response by Peralta et al to Letter Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial".

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leslie A McClure Research Topics

Disease

71	Stroke (Strokes) 01/2022 - 02/2007
21	Lacunar Stroke 01/2021 - 01/2011
15	Cognitive Dysfunction 04/2021 - 05/2008
12	Ischemic Stroke 12/2021 - 08/2012
10	Hypertension (High Blood Pressure) 01/2022 - 01/2011
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2012
6	Asthma (Bronchial Asthma) 12/2012 - 02/2009
5	Diabetes Mellitus 01/2021 - 06/2014
5	Coronary Disease (Coronary Heart Disease) 01/2019 - 09/2009
5	Atrial Fibrillation 08/2017 - 04/2012
3	Chronic Disease (Chronic Diseases) 01/2022 - 05/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2019
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2010
2	Heart Diseases (Heart Disease) 01/2019 - 01/2017
2	Hemorrhage 05/2015 - 08/2012
2	Infarction (Infarctions) 10/2014 - 09/2014
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 06/2014 - 04/2012
1	Syncope (Fainting) 12/2021
1	Autistic Disorder (Autism) 11/2021
1	Neurodevelopmental Disorders 11/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Obstructive Sleep Apnea 01/2021
1	Insulin Resistance 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 08/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Sepsis (Septicemia) 01/2018
1	Atherosclerosis 01/2018
1	Neutropenia 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2017
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2017
1	Myocardial Infarction 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Heart Failure 01/2017

Drug/Important Bio-Agent (IBA)

10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2017 - 02/2007
8	Particulate MatterIBA 01/2022 - 01/2013
7	Clopidogrel (Plavix)FDA Link 08/2017 - 02/2007
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
5	C-Reactive ProteinIBA 01/2020 - 09/2009
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 04/2012
3	MagnesiumIBA 04/2021 - 02/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2011
3	SmokeIBA 01/2019 - 04/2009
3	SeleniumIBA 01/2018 - 02/2017
3	ArsenicIBA 01/2018 - 02/2017
3	Trace Elements (Biometals)IBA 01/2018 - 02/2017
3	MercuryIBA 01/2018 - 02/2017
3	Tobacco Smoke Pollution (Passive Smoking)IBA 12/2015 - 09/2011
3	CreatinineIBA 09/2011 - 08/2008
2	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2016
2	insulin receptor-related receptor (IRR)IBA 01/2021 - 01/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2016
2	hydroxide ionIBA 08/2019 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2016
2	CytokinesIBA 01/2019 - 01/2018
2	LDL CholesterolIBA 01/2018 - 01/2010
2	P 11 (P-11)IBA 01/2017 - 04/2012
2	Warfarin (Coumadin)FDA LinkGeneric 07/2013 - 04/2012
2	Hand SanitizersIBA 12/2012 - 06/2011
2	AlbuminsIBA 09/2011 - 08/2011
2	Hemoglobins (Hemoglobin)IBA 12/2010 - 05/2008
2	Digoxin (Digitek)FDA LinkGeneric 12/2009 - 07/2009
1	FatsIBA 12/2021
1	AntioxidantsIBA 12/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2021
1	ZincIBA 12/2021
1	phthalic acid (phthalate)IBA 11/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	neuromedin NIBA 01/2021
1	NeurotensinIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	CalciumIBA 09/2019
1	CholesterolIBA 09/2019
1	InterleukinsIBA 01/2019
1	trandolapril (Mavik)FDA LinkGeneric 01/2019
1	Verapamil (Calan)FDA LinkGeneric 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	monomethylarsonic acid (MSMA)IBA 01/2018
1	CadmiumIBA 01/2018
1	Galectin 3 (LGALS3)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	Polyvinyl Chloride (PVC)IBA 01/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2016
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2016
1	CD40 Ligand (CD40L)IBA 03/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2016

Therapy/Procedure

32	Secondary Prevention 12/2021 - 02/2007
10	Therapeutics 01/2017 - 05/2002
2	Hand Hygiene 12/2012 - 06/2011
2	Liver Transplantation 12/2002 - 05/2002
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2017
1	Mechanical Ventilators (Ventilator) 01/2017
1	Continuous Positive Airway Pressure 01/2017